Luke M. Beshar
CIK: 0001192128
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TARA
Protara Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About BESHAR LUKE M
BESHAR LUKE M (SEC CIK 0001192128) files insider reports with the SEC as Director of Protara Therapeutics, Inc. (TARA).
Signal8 holds 2 ownership filings by BESHAR LUKE M, all Form 4s, filed between Jun 13, 2025 and Jun 16, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BESHAR LUKE M's filings is in NEW YORK, NY.
Recent filings by BESHAR LUKE M
Other insiders filing for Protara Therapeutics, Inc. (TARA)
- Shefferman Jesse, CEO and President
- Levy Richard S, Director
- Solomon Michael Edward, Director
- Smith Cynthia, Director
- SARGEN GREGORY, Director
- Huang Jane, Director